Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE1025.955.35 (+0.52 %)

PREV CLOSE ( ) 1020.60

OPEN PRICE ( ) 1013.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9074

TODAY'S LOW / HIGH ( )987.05 1026.80

52 WK LOW / HIGH ( )987.05 2149.9

NSE1025.105.1 (+0.5 %)

PREV CLOSE( ) 1020.00

OPEN PRICE ( ) 1016.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 202540

TODAY'S LOW / HIGH( ) 987.00 1030.00

52 WK LOW / HIGH ( )987 2150.4

Chairman	Sudhir Vaid
Managing Director	Sudhir Vaid
Company Secretary	Paritosh Trivedi
Non Executive Director	Ravi Kapoor Rajiv Ambrish Agarwal
Joint Managing Director	Ankur Vaid
Non Executive Independent Director	Bharti Khanna Amitabh Thakore Arvind Agarwal Jayaram Easwaran Mandayam Chakravarthy Sriraman

Incorporation Year : 1984

Registered Office :

Address : 1482-1486 ,Trasad Road,Dholka Ahmedabad Dist,
Gujarat-382225 .

Phone : 02714-222604 / 398200

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE